Background and aims: In recent years it has been proposed that hypertension is part of a cluster of metabolic risk factors (syndrome X) involving hyperlipidaemia and hyperglycaemia, with hyperinsulinaemia as the common link. This study has investigated: (1) the prevalence of the metabolic syndrome and its component variables and their relationship to body mass index (BMI) and non-fasting insulin levels in a general population; and (2) the distribution and clustering of metabolic variables in normotensives and hypertensives. Methods: Cross-sectional study of 5222 men aged 40-59 years with no history of coronary heart disease (CHD), diabetes mellitus or stroke drawn from general practices in 18 British towns. The men were a subgroup of the 7735 men in the British Regional Heart Study (BRHS) cohort whose baseline non-fasting serum was analysed for insulin, using a specific ELISA method. Main outcome measures: Hyperinsulinaemia, hyperglycaemia, high serum total cholesterol, high triglyceride and hyperuricaemia were defined as the top 20% of the distribution in the 5222 men. Low HDL-cholesterol was defined as the bottom 20%. Results: BMI and non-fasting insulin were both significantly and strongly associated with non-diabetic hyperglycaemia, lipid abnormalities (HDL-cholesterol, triglyceride and total cholesterol) and hyperuricaemia. BMI was strongly associated with hypertension whereas
Introduction
The association between hypertension and metabolic abnormalities, in particular raised blood glucose and blood lipid levels, has frequently been observed in population studies. [1] [2] [3] [4] [5] [6] [7] The excess prevalence of cardiovascular risk factors in hypertensives has been considered to be due to the effects of obesity. More recently it has been proposed that hypertension is part of a cluster of metabolic risk factors (a metabolic syndrome X) involving hyperlipidaemia and hyperglycaemia, with insulin resistance or hyperinsulinaemia as the common link. [8] [9] [10] However, the relation between hyperinsulinaemia and hypertension remains controversial [11] [12] [13] non-fasting insulin showed a much weaker relationship which was abolished after adjustment for BMI. However, only 2.9% of men showed the 'full metabolic syndrome' (hypertension, hyperglycaemia and dyslipidaemia) and a large proportion of these men were hyperinsulinaemic (65%) or obese (47%). Dyslipidaemia (any one of low-HDL-cholesterol, high triglyceride or high cholesterol) was common in both normotensives and hypertensives (40.5% vs 46.4%). Hypertensives showed significantly higher levels of total cholesterol, triglyceride, blood glucose, urate and more clustering of hyperglycaemia and dyslipidaemia than normotensives even after adjustment for BMI. Conclusion: Hypertensives were more likely to have lipid abnormalities and clustering of risk factors than normotensives even after adjustment for BMI. The metabolic syndrome is more strongly associated with hyperinsulinaemia than with obesity but it is relatively uncommon in men with no history of cardiovascular disease or diabetes. Given the weak relationship between hypertension and hyperinsulinaemia, the latter is unlikely to explain the higher levels of lipid abnormalities and clustering seen in hypertensives. Overweight/obesity may be primarily involved in the pathways to hypertension and lipid abnormalities but the unravelling of these relationships require more specific measures of adipose tissue distribution, composition and function.
studies have looked at the frequency of the metabolic syndrome in a general population. The purpose of this study is: (1) to examine the prevalence of the metabolic syndrome and its component variables and their relationship to body mass index (BMI) and insulin levels in a general population; (2) to examine the distribution and clustering of metabolic variables in hypertensive and normotensive men; and (3) to determine the extent to which these relationships are associated with serum insulin and obesity.
Subjects and methods
The British Regional Heart Study is a large prospective study of cardiovascular disease comprising 7735 men aged 40-59 selected from the age-sex registers of one group general practice in each of 24 towns in England, Wales and Scotland. The criteria for selecting the town, the general practice and the subjects as well as the methods of data collection, have been reported. 14 The overall response rate was 78%. Research nurses administered to each man a standard questionnaire that included questions on smoking habits, alcohol intake, physical activity and medical history. The men were asked whether a doctor had ever told them that they had angina or myocardial infarction (heart attack, coronary thrombosis), stroke, diabetes and a number of other disorders. Several physical measurements were made including height and weight, and venous blood samples (non-fasting) were taken for measurement of biochemical and haematological variables. Aliquots of serum from the men in the 7th to 24th towns visited (n = 5663) were stored at −20°C. Because of the influence that pre-existing cardiovascular disease and diabetes mellitus may have on metabolic risk factor levels, men with recall of doctor diagnosis of stroke or coronary heart disease (CHD), known diabetics at screening and men with asymptomatic hyperglycaemia of diabetic proportions (у11.1 mmol/l) (n = 441) have been excluded. After exclusion, data were available for a group of 5222 men, the subjects of this study.
Baseline measurements
BMI calculated as weight/height 2 was used as an index of relative weight. Obesity is defined as BMI у27.85 kg/m 2 , the top fifth of the distribution in these 5222 men. Haematocrit was determined using a Coulter S electronic particle counter (Coulter Electronics Ltd, Luton, UK) calibrated daily with Coulter $C. 15 Heart rate was measured from the resting electrocardiogram. 16 Elevated haematocrit and elevated heart rate were defined as the top fifth of the distribution.
Blood pressure: The men attended the examination centre over a 10 h period between 8.30 am and 6.30 pm on weekdays and were not asked to fast or to abstain from alcohol beforehand. The London School of Hygiene sphygmomanometer was used to measure blood pressure (BP) twice in succession with the subjects seated and the arm supported on a cushion. The mean of the two readings was used in the analysis and all BP readings were adjusted for observer variation within each town. 17 Hypertension was defined as men who had systolic BP у160 mm Hg or diastolic BP у95 mmHg or those who were on antihypertensive treatment.
Blood lipids:
All the blood samples were obtained in the non-fasting state between 8.30 am and 6.30 pm. Detailed information on blood lipid measurements have been published. 18 Adjustments were made for the marked diurnal variation in serum triglyceride concentration Blood glucose: Glucose was analysed by a glucose oxidase method using automated analyser (Technicon SMA 12/60). Diurnal variation in glucose levels was modest and no adjustments were made for diurnal variation. 19 Serum insulin: Serum insulin concentration was determined by a two-site enzyme-linked immunoadsorbant assay (ELISA) using commercially available monoclonal antibodies raised against human insulin (Novo Nordisk A/S: Denmark), which do not cross-react with proinsulin. 20 Analyses were performed in the Department of Medicine, University of Newcastle upon Tyne, UK, on non-fasting samples, which had been stored at −20°C for between 13 to 15 years. In this laboratory no change in insulin levels was detected in repeat assays of 34 samples, stored at −20°C over an 8-year period (mean difference 0.19 mU/L, P = 0.5). The lower limit of detection for the ELISA was 1 mU/L and the interassay coefficients of variation were 5.5% at 8.8 mU/L, 5.9% at 21.6 mU/L and 7.5% at 44.8 mU/L. There were significant diurnal variation in serum insulin levels, presumably related to meals with peaks at 08.00, 09.00, 13.00, 14.00, 15.00 and 18.00 hours, troughs at 11.00 and 16.00 and intermediate levels at 10 .00, 12.00 17.00 and 19.00 hours. Peak levels (hourly geometric mean) ranged from 13.6 mU/L to 18.4 mU/L, the trough levels were 10.3 mU/L and 10.4 mU/L and the intermediate levels ranged from 11.6 mU/L to 11.7 mU/L. Adjustments were therefore made for the diurnal variation in serum insulin.
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Definition of metabolic abnormalities
Metabolic abnormalities included high serum total cholesterol (у7.1 mmol/l), high serum triglyceride (у2.32 mmol/l), high serum urate (у410 umol/l), high blood glucose (у6.1 mmol/l), high serum insulin (у22.8 ml/l), all defined as the top fifth of the distribution in the 5222 men, and low HDL-cholesterol (Ͻ0.93 mmol/l), defined as the bottom fifth of the distribution. Dyslipidaemia was defined as having a high serum total cholesterol, high serum triglyceride or low HDL-cholesterol. The metabolic syndrome (syndrome X) was defined as the presence of hypertension, hyperglycaemia and high triglyceride or low HDL-cholesterol, the main features of the syndrome. 8 
Statistical analysis
The proportion of men with high levels for each of the metabolic factors was examined in relation to quintiles of BMI and serum insulin in normotensive and hypertensive men. Logistic regression was used to obtained adjusted relative odds for the fifth quintile compared to the first quintile and for hypertensive compared to normotensive men.
Results
BMI, serum insulin and metabolic abnormalities
BMI and serum insulin were strongly correlated (r = 0.32; P Ͻ 0.0001). The relationships of BMI and insulin with metabolic abnormalities as well as with biological factors previously shown to be strongly associated with hypertension viz. haematocrit and heart rate, were examined. Figure  1(a) shows the prevalence of men with hypertension, high triglyceride, high glucose and low HDLcholesterol, components of the metabolic syndrome, by fifths of the BMI and insulin distributions. BMI was strongly associated with hypertension whereas insulin showed a much weaker association. Conversely blood glucose was more strongly associated with insulin than with BMI. Both BMI and insulin showed strong associations with HDL-cholesterol and triglyceride (which are themselves highly and inversely correlated r = −0.46; P Ͻ 0.0001).
Components of the metabolic syndrome:
Other metabolic abnormalities: Figure 1(b) shows that BMI and insulin were both significantly and similarly associated with high total cholesterol, urate, haematocrit and heart rate.
Since BMI and insulin were strongly correlated, further adjustments were made for the confounding effect of each of them. Table 1 shows the relative odds (top fifth vs bottom fifth, inverse for HDLcholesterol) of having these abnormalities by BMI and insulin levels, adjusting first for age and then in addition for each other. With the exception of heart rate all the relationships between BMI and these metabolic factors remained significant. For insulin, all the relationships except with hypertension remained significant. 
The metabolic syndrome (syndrome X)
Only 2.9% (153 men) had the 'complete' metabolic syndrome (hypertension, hyperglycaemia and high triglyceride or low HDL-cholesterol). The prevalence of the metabolic syndrome increased with increasing BMI and even more markedly with increasing insulin levels ( Table 2) . Men in the top fifth of the insulin distribution were 36 times more likely to have the syndrome than men in the bottom fifth. For BMI the relative odds (5th quintile vs 1st) was about eight-fold (5th quintile vs 1st quintile). When the prevalence of the metabolic syndrome was examined by hyperinsulinaemia and obesity (Table  3) , hyperinsulinaemia appeared to have a stronger association with the metabolic syndrome than obesity. Two-thirds (65%) of men with the metabolic syndrome had elevated insulin and 47% were obese. Table 4 shows the prevalence of metabolic abnormalities in normotensive and hypertensive men. Hypertension was significantly associated with higher rates of high serum total cholesterol, high triglycerides, high urate, high haematocrit, high blood glucose and elevated heart rate even after adjust- ment for age and BMI, although the adjustment for BMI made a significant impact on the strength of the association. Dyslipidaemia was common in the total cohort and was slightly higher in hypertensive than normotensive men, but this difference was abolished after adjusting for BMI. Hypertensives showed significantly higher rates of hyperinsulinaemia but this was due to the higher rates of obesity and adjustment for BMI abolished the difference. However, hypertensives showed higher rates of clustering of metabolic factors (hyperglycaemia and dyslipidaemia) which was to a considerable degree accounted for by BMI. Amongst hypertensive men there were higher rates of men with the clustering of the components of syndrome X (high blood glucose and high triglyceride/low HDL-C) even after adjustment for BMI. However when insulin was included in the cluster the difference was of marginal significance after adjustment for BMI. The factors shown to be associated with hypertension remained significant even after additional adjustment for lifestyle characteristics viz. smoking, physical activity and alcohol intake. Exclusion of the 179 men on antihypertensive treatment made no difference to the relationships seen. We also examined the relationship between hypertension and metabolic abnormalities separately by tertiles of the BMI distribution (Ͻ24.0, 24.0-26.6 and Ͼ26.6 kg/m 2 ). The relationships seen in Table 4 were present at all levels of BMI but were most marked in the leanest group (BMI Ͻ24.0 kg/m 2 ). Haematocrit, serum urate and heart rate are strongly associated with hypertension and have also been shown to be associated with blood lipids and blood glucose. 15, 16, 21 We have therefore examined the relationship between hypertension and blood glucose, triglyceride and total cholesterol adjusting in addition for haematocrit, urate and heart rate. The significant relationships between hypertension and hypercholesterolaemia and between hypertension and hypertriglyceridaemia were abolished after this further adjustment (adjusted relative odds RO = 1.0). The relationship with hyperglycaemia, however, remained significant (adjusted relative odds RO = 1.2; P = 0.01).
Hypertension and metabolic disturbances
Effect of time of sampling on the relationship between serum insulin and the metabolic factors
Since insulin was based on non-fasting measurements made at different times of the day, serum insulin values used in the analyses presented in this paper are adjusted for time of sampling. This is presumably a crude proxy for the adjustment for the effect of meals. We have, however, examined the relationships at different times of the day between the metabolic syndrome and serum insulin unadjusted for time of sampling; peak (n = 2102), intermediate (n = 1877) and trough (n = 1247) (see Methods) The relationships were similar irrespective of time of sampling (data not presented).
Discussion
In this study of middle-aged British men, hypertension was associated with several metabolic abnormalities including high blood glucose, high triglyceride, high serum total cholesterol and high urate. These associations were independent of BMI although the adjustment for BMI had a considerable effect on the relationship. The relationship between hypertension and HDL-cholesterol and between hypertension and insulin appeared to be confounded by BMI because adjustment for BMI abolished these associations. All these findings are consistent with data from other cross-sectional studies.
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Hypertension and dyslipidaemia
Although many studies have indicated the presence of dyslipidaemia in the majority of hypertensives, it should be noted that the number of men with dyslipidaemia (at least one of low HDL-cholesterol, high triglyceride or high total cholesterol) in the general population was high (over 40%). Thus the finding that dyslipidaemia was present in nearly 50% of hypertensives does not suggest any particularly marked association. The increased prevalence of dyslipidaemia in hypertensives was largely due to the higher rates of obesity. However hypertension was apparently associated with raised total cholesterol and triglyceride (but not low HDL-cholesterol) which was not fully accounted for by BMI.
Insulin and components of the metabolic syndrome
In recent years attention has focused on the clustering of risk factors in hypertensives and a specific syndrome has been proposed which includes impaired glucose tolerance, low HDL-cholesterol and high triglyceride with insulin-resistance or hyperinsulinaemia as the common link. [8] [9] [10] The most consistent finding in cross-sectional studies is the association between high serum insulin and triglyceride and low HDL-cholesterol and this pattern of dyslipidaemia is regarded as integral to the insulin resistance syndrome. 8 The positive associations between insulin and triglyceride, uric acid, haematocrit and heart rate and the inverse associations between insulin and HDL-cholesterol in this study are entirely consistent with a considerable body of data from cross-sectional studies. 9, [22] [23] [24] [25] [26] [27] [28] The most striking association was that seen between insulin and blood glucose, followed by the association with high triglyceride. Hyperuricaemia is also correlated with hyperinsulinaemia and has been shown to be associated with other components of the syndrome. It has been suggested that urate should be added to the components of the insulin resistance syndrome. 29 Polycythaemia has been reported in visceral as opposed to subcutaneous obesity (the former being associated with hyperinsulinaemia). [30] [31] In a recent report from the British Regional Heart Study elevated haematocrit was shown to be significantly predictive of non-insulin dependent diabetes. 32 These findings suggest that insulin resistance is also associated with haemorheological abnormalities including raised haematocrit, which is a major determinant of whole blood viscosity.
Insulin and blood pressure
By contrast, no association was seen between hypertension and insulin after adjustment for BMI and this finding does not support the hypothesis of a fundamental role for insulin in the development of essential hypertension. Epidemiological data on the association between insulin and BP are markedly inconsistent. [11] [12] [13] While several studies have reported significant association between hyperinsulinaemia and hypertension, 9, 10, 33, 34 others have found a weak or no relationship between insulin and BP when BMI is taken into account. [35] [36] [37] [38] [39] It is suggested that the inconsistency in the associations between insulin and BP is strongly likely to be due to confounding 11 and our data are consistent with this. Given the weak relationship between insulin and hypertension, insulin is unlikely to explain the link between hypertension and metabolic abnormalities. Urate, heart rate and haematocrit have all been shown to be strongly associated with both hypertension and blood lipids in several population studies. 15, 16, 21, [40] [41] [42] Although these factors have links with overweight/obesity, the associations have been shown to be independent of BMI. In the present study heart rate, urate and haematocrit appear to account for (in statistical terms) the relationship between hypertension and high triglyceride and total cholesterol. This issue has seldom been examined in other epidemiological studies and suggests a role for these factors in the link between hypertension and dyslipidaemia. It could well be that overweight/obesity provides the background to these complex interrelationships. Adjustment for BMI does not fully account for the observed association but BMI is only a crude measure of the magni-tude, distribution and effects of adipose tissue accumulation.
Insulin and pre-diabetic state
Cardiovascular risk factors which were associated with increased risk of non-insulin dependent diabetes melitus (NIDDM) in longitudinal studies were associated with higher insulin levels suggesting that high insulin may be a marker of the prediabetic state. However, in the present study the relationship between elevated insulin and the biological factors, in particular serum triglyceride and HDL-cholesterol concentrations, were similar at all levels of blood glucose (data not shown). It might have been anticipated that those men most at risk of diabetes (ie, prediabetic) would be in the upper part of the glucose distribution. Thus it is possible, at least in the case of serum triglyceride the influence of hyperinsulinaemia (or the insulin resistance leading to it) is independent of glycaemia and of the prediabetic state.
Bias
The use of non-fasting insulin measurements, adjusted for time of sampling has almost certainly increased the amount of random error or 'noise' in the data relative to the use of insulin measured under fasting conditions. However, the associations between non-fasting insulin and cardiovascular risk factors, such as BMI, lipids and BP, are consistent with those reported with fasting and post-load insulin in other studies. 43 Furthermore the correlations between insulin and these risk factors were similar irrespective of time of sampling. In a previous paper from this study which presented correlation coefficients between insulin and biological risk factors, 20 the interrelations with biological risk factors are virtually identical to those reported from a populationbased study in eastern Finland in which fasting and 2-h plasma insulin values were measured. 43 This strongly suggests that the use of non-fasting insulin in the present investigation has not been associated with systematic measurement error.
The metabolic syndrome
The majority of studies which have stressed the common occurrence of the metabolic syndrome in hypertensives have focused on clinical settings or on highly selected population samples. Reports on the prevalence rate of the metabolic syndrome in population-based studies are limited, but the prevalence of syndrome X (variously defined) appears to be low ranging from 0.7% in the San Antonio Study, USA 26 to 2.4% in the RIFLE study, Italy 44 to 3.7% in the study of Swedish men born in 1913. 7 The prevalence of syndrome X will obviously depend on the criteria for definition and on the cut-off points used. In this study the prevalence was 2.9% and would be even lower if other factors were included, eg, urate. Although comparisons across different studies are difficult because of different criteria and cut-off points used, the findings indicate that the metabolic syndrome X is uncommon in populationbased studies. In the present investigation, the syndrome was more closely associated with serum insulin than with BMI. The clustering of high blood glucose and high triglyceride/low HDL-cholesterol although higher in hypertensives, was only present in 10% of hypertensives and this was even lower (6.7%) when serum insulin was added to the cluster.
Conclusion
There was no association between hypertension and insulin after adjustment for BMI. Hypertensives were more likely to have lipid abnormalities and clustering of risk factors than normotensives even after adjustment for BMI. The metabolic syndrome X is more strongly related to insulin than to BMI, but it is relatively uncommon in men with no diagnosis of cardiovascular disease or diabetes. Given the weak relationship between hypertension and serum insulin, the latter is unlikely to explain the clustering of risk factors seen in hypertensives. Overweight/obesity may provide the background to these complex interrelationships, but their unravelling will require more specific measures of adipose tissue distribution, composition and function for all of which BMI is an extremely crude proxy.
